Ticker Symbol: ACRS
Aclaris Therapeutics Inc
$14.18 - 12-11-2024 4 p.m. ET
Exchange: NASDAQ
Country:
US
Currency:
USD
Asset
Type: Common Stock
CIK:0001557746
Company Profile
aclaris therapeutics, inc. is a dermatologist-led biopharmaceutical company committed to identifying, developing and commercializing innovative therapies to address significant unmet needs in dermatology, both medical and aesthetic, and immunology. aclaris is focused on market segments with no fda-approved medications or where treatment gaps exist. aclaris was founded by dermatologists and is led by a team with extensive experience in developing and commercializing dermatologic treatments.
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
Standard Industrial Classification Code (SIC code): 2834
Address: 640 Lee Rd Ste 200
Website: https://www.aclaristx.com/
CEO: Neal Walker
Tags:
- Health Technology
- Pharmaceuticals: Other
- Manufacturing
- Pharmaceutical Preparation Manufacturing
Pricing
Last Updated: October 20, 2023 03:00 PM EST
Previous Close: $5.28
Change:
-$0.04
(
-0.75%)
Days Range: $5.14 - $5.39
Beta: 0.95
52wk. High: $18.96
52wk. Low: $5.09
Ytd. Change -67.23%
50 Day Moving Average: $6.67
200 Day Moving Average: $8.49
Shares Outstanding: 70794642
Valuation
Market Cap: 37.4B
PE Ratio: -3.41
EPS (TTM): -1.55
Dividends
Dividend Per Share (TTM): -
Dividend Yield (TTM): 0.00%
Ex-Dividend Date: N/A